APP and Alzheimer disease: The evidence that PSEN mutations cause the generation of longer Aβ-peptides, however, suggests that an inverse mechanism, shifting the production to smaller peptides by stabilizing the APP-γ-secretase substrate-enzyme interaction could have a profound protective effect on the pathogenesis of AD.